Clinical COPD questionnaire score (CCQ) and mortality

International Journal of COPD

Volumn 7, Issue , 2012, Pages 833-842

  Sundh, Josefin ^a   Janson, Christer ^b   Lisspers, Karin ^b   Montgomery, Scott ^a,c,d   Ställberg, Björn ^b  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Health related quality of life (HRQL); Health status; Standardized mortality ratios (SMR)

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; TIOTROPIUM BROMIDE;

ADULT; AGE DISTRIBUTION; AGED; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT TOOL; CLINICAL COPD QUESTIONNAIRE SCORE; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; FORCED EXPIRATORY VOLUME; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MONOTHERAPY; MORTALITY; OVERALL SURVIVAL; PATIENT SELECTION; POPULATION RESEARCH; PREDICTIVE VALUE; PRIMARY MEDICAL CARE; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SECONDARY HEALTH CARE; SEX DIFFERENCE; SPIROMETRY; SWEDISH;

AGED; COMORBIDITY; FEMALE; HEALTH STATUS; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SECONDARY CARE; SPIROMETRY; SWEDEN; TIME FACTORS;

EID: 84872318445     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S38119     Document Type: Review

References (26)

1. National Heart, Lung, and Blood Institute. World Health Organization. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report 2001. Bethesda: National Institutes of Health; 2002. Available from: http://www.goldcopd.org/Guidelines/guidelines-global-strategy-for-diagnosis-management-2001.html. Accessed May 24, 2012.
2. Alonso J, Ferrer M, Gandek B, et al; IQOL Project Group. Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project. Qual Life Res. Mar 2004;13(2):283-298.
3. Curtis JR, Martin DP, Martin TR. Patient-assessed health outcomes in chronic lung disease: what are they, how do they help us, and where do we go from here? Am J Respir Crit Care Med. 1997;156(4 Pt 1): 1032-1039.
4. Domingo-Salvany A, Lamarca R, Ferrer M, et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166(5):680-685.
5. Almagro P, Calbo E, Ochoa de Echagüen A, et al. Mortality after hospitalization for COPD. Chest. 2002;121(5):1441-1448.
6. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med. 2003;167(4):544-549.
7. Gudmundsson G, Gislason T, Lindberg E, et al. Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity. Respir Res. 2006;7:109.
8. Halpin DM, Peterson S, Larsson TP, Calverley PM. Identifying COPD patients at increased risk of mortality: predictive value of clinical study baseline data. Respir Med. 2008;102(11):1615-1624.
9. Antonelli-Incalzi R, Pedone C, Scarlata S, et al. Correlates of mortality in elderly COPD patients: focus on health-related quality of life. Respirology. 2009;14(1):98-104.
10. Fan VS, Curtis JR, Tu SP, McDonell MB, Fihn SD; Ambulatory Care Quality Improvement Project Investigators. Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases. Chest. 2002;122(2):429-436.
11. van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003;1:13.
12. Kocks JW, Tuinenga MG, Uil SM, van den Berg JW, Ståhl E, van der Molen T. Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir Res. 2006;7:62.
13. Kocks JW, Kerstjens HA, Snijders SL, et al. Health status in routine clinical practice: validity of the clinical COPD questionnaire at the individual patient level. Health Qual Life Outcomes. 2010;8:135.
14. Reda AA, Kotz D, Kocks JW, Wesseling G, van Schayck CP. Reliability and validity of the clinical COPD questionnaire and chronic respiratory questionnaire. Respir Med. 2010;104(11):1675-1682.
15. Bourbeau J, Ford G, Zackon H, Pinsky N, Lee J, Ruberto G. Impact on patients' health status following early identification of a COPD exacerbation. Eur Respir J. 2007;30(5):907-913.
16. Ställberg B, Selroos O, Vogelmeier C, Andersson E, Ekström T, Larsson K. Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD. A double-blind, randomised, non-inferiority, parallel-group, multicentre study. Respir Res. 2009;10:11.
17. Sundh J, Ställberg B, Lisspers K, Montgomery SM, Janson C. Co-morbidity, body mass index and quality of life in COPD using the Clinical COPD Questionnaire. COPD. 2011;8(3):173-181.
18. Ställberg B, Lisspers K, Hasselgren M, Janson C, Johansson G, Svärdsudd K. Asthma control in primary care in Sweden: a comparison between 2001 and 2005. Prim Care Respir J. 2009;18(4):279-286.
19. Arne M, Lisspers K, Ställberg B, et al. How often is diagnosis of COPD confirmed with spirometry? Respir Med. 2010;104(4):550-556.
20. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993;16:5-40.
21. Ställberg B, Nokela M, Ehrs PO, Hjemdal P, Jonsson EW. Validation of the clinical COPD Questionnaire (CCQ) in primary care. Health Qual Life Outcomes. 2009;7:26.
22. Tsiligianni G, Riemersma R, Price D, et al. Health status of COPD patients in clinical practice in three countries in Europe [Abstract]. Am J Respir Crit Care Med. 2010;181:A2855.
23. The statistic data base of the National Board of Health and Welfare, Sweden. Available from: http://www.socialstyrelsen.se/statistik/statistikdatabas. Accessed August 16, 2011.
24. Tanash HA, Nilsson PM, Nilsson JA, Piitulainen E. Survival in severe alpha-1-antitrypsin deficiency (PiZZ). Respir Res. 2010;11:44.
25. Ekström M, Franklin KA, Ström KE. Increased relative mortality in women with severe oxygen-dependent COPD. Chest. 2010;137(1): 31-36.
26. Bolton CE, Ionescu AA, Edwards PH, Faulkner TA, Edwards SM, Shale DJ. Attaining a correct diagnosis of COPD in general practice. Respir Med. 2005;99(4):493-500.